Slide background

PIPELINE

Pipeline

NeuClone is co-developing ten biosimilars with the Serum Institute of India, alongside a portfolio of separate biosimilars for worldwide outlicense. The development stage of the first four products is outlined below.

Timeline 4
Contact Us

Not readable? Change text.